サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1792289

遺伝子発現解析の市場レポート：製品・サービス別、技術別、能力別、エンドユーザー別、地域別、2025～2033年

Gene Expression Analysis Market Report by Products & Services, Technology (Polymerase Chain Reaction, Next Generation Sequencing, DNA Microarray, Sanger Sequencing, and Others), Capacity, End-User, and Region 2025-2033

出版日
発行
IMARC
ページ情報
英文 136 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.55円
遺伝子発現解析の市場レポート：製品・サービス別、技術別、能力別、エンドユーザー別、地域別、2025～2033年
出版日: 2025年08月01日
発行: IMARC
ページ情報: 英文 136 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の遺伝子発現解析の市場規模は2024年に56億米ドルに達しました。IMARC Groupは、市場は2033年までに117億米ドルに達し、2025～2033年にかけて8.21%の成長率（CAGR）を示すと予測しています。

遺伝子発現解析（GEA）とは、生物システムの挙動を調べるために遺伝子からデータを抽出する方法です。遺伝子の転写、翻訳、タンパク質の翻訳後修飾、RNAスプライシングなど、さまざまなプロセスが含まれます。この分析から得られたデータは、タンパク質、リボ核酸（RNA）、様々な微生物学的産物の生産に利用されます。さらに、新薬の開発や既存の診断法の改良にも活用されています。GEAは現在、薬理ゲノミクス、バイオマーキング、毒物学、診断学に幅広く応用されており、多くの医学的疾患の原因メカニズムを説明する上で不可欠であると広く考えられています。

個別化医療に対する需要の高まりとともに、標的分子治療薬の採用が増加していることも、市場の成長を促す主な要因の一つです。GEAは分子生物学的研究において強力なツールであることが証明されており、遺伝子の機能を理解し、病気を診断し、医薬品開発を促進するために使用されています。さらに、がん、結核、心血管疾患、遺伝性疾患などの慢性疾患の有病率の増加が、市場成長を大きく後押ししています。さらに、これらの病気を治療するための個別化医薬品の開発により、個々の患者の要求に応じて診断法や治療法を変更することが可能になりました。さらに、次世代シーケンシング（NGS）の登場、ゲノムデータベースの開発、GEAの成功率の向上、遺伝子治療の研究開発（R&D）への注力強化など、さまざまな技術的進歩が市場成長をさらに促進すると予測されます。

本レポートで扱う主な質問

  • 世界の遺伝子発現解析の市場規模は？
  • 世界の遺伝子発現解析市場の2025～2033年の予想成長率は？
  • 世界の遺伝子発現解析市場を牽引する主要因は？
  • 世界の遺伝子発現解析市場におけるCOVID-19の影響は？
  • 製品・サービス別の市場内訳は？
  • 技術別の市場内訳は？
  • 能力別の市場内訳は？
  • エンドユーザー別の市場内訳は？
  • 世界の遺伝子発現解析市場における主要地域は？
  • 世界の遺伝子発現解析市場における主要プレイヤー/企業は？

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査の目的
  • ステークホルダー
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要業界動向

第5章 世界の遺伝子発現解析市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳：製品・サービス別

  • 消耗品
  • 機器
  • サービス

第7章 市場内訳：技術別

  • ポリメラーゼ連鎖反応（PCR）
  • 次世代シーケンシング（NGS）
  • DNAマイクロアレイ
  • サンガーシーケンシング
  • その他

第8章 市場内訳：能力別

  • ロー～ミッドプレックス遺伝子発現解析
  • ハイプレックス遺伝子発現解析

第9章 市場内訳：エンドユーザー別

  • 製薬・バイオテクノロジー企業
  • 学術機関・研究センター
  • その他

第10章 市場内訳：地域別

  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • ロシア
    • その他
  • アジア太平洋地域
    • 中国
    • 日本
    • インド
    • 韓国
    • オーストラリア
    • インドネシア
    • その他
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • チリ
    • ペルー
    • その他
  • 中東・アフリカ
    • トルコ
    • サウジアラビア
    • イラン
    • アラブ首長国連邦
    • その他

第11章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第12章 バリューチェーン分析

  • 概要
  • インバウンド物流
  • オペレーション
  • アウトバウンド物流
  • マーケティングとセールス
  • サービス

第13章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第14章 価格指標

第15章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Agilent Technologies, Inc.
    • BGI Genomics Co., Ltd.
    • Bio-Rad Laboratories, Inc.
    • Eurofins GSC Lux SARL
    • F. Hoffmann-La Roche Ltd
    • GE Healthcare
    • Illumina, Inc.
    • Oxford Gene Technology IP Limited
    • Pacific Biosciences of California Inc.
    • PerkinElmer Inc.
    • QIAGEN GmbH
    • Thermo Fisher Scientific Inc.
図表

List of Figures

  • Figure 1: Global: Gene Expression Analysis Market: Major Drivers and Challenges
  • Figure 2: Global: Gene Expression Analysis Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Gene Expression Analysis Market: Breakup by Products & Services (in %), 2024
  • Figure 4: Global: Gene Expression Analysis Market: Breakup by Technology (in %), 2024
  • Figure 5: Global: Gene Expression Analysis Market: Breakup by Capacity (in %), 2024
  • Figure 6: Global: Gene Expression Analysis Market: Breakup by End-User (in %), 2024
  • Figure 7: Global: Gene Expression Analysis Market: Breakup by Region (in %), 2024
  • Figure 8: Global: Gene Expression Analysis Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 9: Global: Gene Expression Analysis (Consumables) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 10: Global: Gene Expression Analysis (Consumables) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 11: Global: Gene Expression Analysis (Instruments) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 12: Global: Gene Expression Analysis (Instruments) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 13: Global: Gene Expression Analysis (Services) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 14: Global: Gene Expression Analysis (Services) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 15: Global: Gene Expression Analysis (Polymerase Chain Reaction- PCR) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 16: Global: Gene Expression Analysis (Polymerase Chain Reaction- PCR) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 17: Global: Gene Expression Analysis (Next Generation Sequencing- NGS) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 18: Global: Gene Expression Analysis (Next Generation Sequencing- NGS) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 19: Global: Gene Expression Analysis (DNA Microarray) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 20: Global: Gene Expression Analysis (DNA Microarray) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 21: Global: Gene Expression Analysis (Sanger Sequencing) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 22: Global: Gene Expression Analysis (Sanger Sequencing) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 23: Global: Gene Expression Analysis (Others) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 24: Global: Gene Expression Analysis (Others) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 25: Global: Gene Expression Analysis (Low-to Mid-Plex Gene Expression Analysis) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 26: Global: Gene Expression Analysis (Low-to Mid-Plex Gene Expression Analysis) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 27: Global: Gene Expression Analysis (High-Plex Gene Expression Analysis) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 28: Global: Gene Expression Analysis (High-Plex Gene Expression Analysis) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 29: Global: Gene Expression Analysis (Pharmaceutical and Biotech Companies) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 30: Global: Gene Expression Analysis (Pharmaceutical and Biotech Companies) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 31: Global: Gene Expression Analysis (Academic Institutes and Research Centers) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 32: Global: Gene Expression Analysis (Academic Institutes and Research Centers) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 33: Global: Gene Expression Analysis (Other End-Users) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 34: Global: Gene Expression Analysis (Other End-Users) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 35: North America: Gene Expression Analysis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 36: North America: Gene Expression Analysis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 37: United States: Gene Expression Analysis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 38: United States: Gene Expression Analysis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 39: Canada: Gene Expression Analysis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 40: Canada: Gene Expression Analysis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 41: Europe: Gene Expression Analysis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 42: Europe: Gene Expression Analysis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 43: Germany: Gene Expression Analysis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 44: Germany: Gene Expression Analysis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 45: France: Gene Expression Analysis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 46: France: Gene Expression Analysis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 47: United Kingdom: Gene Expression Analysis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 48: United Kingdom: Gene Expression Analysis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 49: Italy: Gene Expression Analysis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 50: Italy: Gene Expression Analysis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 51: Spain: Gene Expression Analysis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 52: Spain: Gene Expression Analysis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 53: Russia: Gene Expression Analysis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 54: Russia: Gene Expression Analysis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 55: Others: Gene Expression Analysis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 56: Others: Gene Expression Analysis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 57: Asia Pacific: Gene Expression Analysis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 58: Asia Pacific: Gene Expression Analysis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 59: China: Gene Expression Analysis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 60: China: Gene Expression Analysis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 61: Japan: Gene Expression Analysis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 62: Japan: Gene Expression Analysis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 63: India: Gene Expression Analysis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 64: India: Gene Expression Analysis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 65: South Korea: Gene Expression Analysis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 66: South Korea: Gene Expression Analysis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 67: Australia: Gene Expression Analysis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 68: Australia: Gene Expression Analysis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 69: Indonesia: Gene Expression Analysis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 70: Indonesia: Gene Expression Analysis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 71: Others: Gene Expression Analysis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 72: Others: Gene Expression Analysis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 73: Latin America: Gene Expression Analysis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 74: Latin America: Gene Expression Analysis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 75: Brazil: Gene Expression Analysis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 76: Brazil: Gene Expression Analysis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 77: Mexico: Gene Expression Analysis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 78: Mexico: Gene Expression Analysis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 79: Argentina: Gene Expression Analysis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 80: Argentina: Gene Expression Analysis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 81: Colombia: Gene Expression Analysis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 82: Colombia: Gene Expression Analysis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 83: Chile: Gene Expression Analysis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 84: Chile: Gene Expression Analysis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 85: Peru: Gene Expression Analysis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 86: Peru: Gene Expression Analysis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 87: Others: Gene Expression Analysis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 88: Others: Gene Expression Analysis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 89: Middle East and Africa: Gene Expression Analysis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 90: Middle East and Africa: Gene Expression Analysis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 91: Turkey: Gene Expression Analysis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 92: Turkey: Gene Expression Analysis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 93: Saudi Arabia: Gene Expression Analysis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 94: Saudi Arabia: Gene Expression Analysis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 95: Iran: Gene Expression Analysis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 96: Iran: Gene Expression Analysis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 97: United Arab Emirates: Gene Expression Analysis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 98: United Arab Emirates: Gene Expression Analysis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 99: Others: Gene Expression Analysis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 100: Others: Gene Expression Analysis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 101: Global: Gene Expression Analysis Industry: SWOT Analysis
  • Figure 102: Global: Gene Expression Analysis Industry: Value Chain Analysis
  • Figure 103: Global: Gene Expression Analysis Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Gene Expression Analysis Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Gene Expression Analysis Market Forecast: Breakup by Products & Services (in Million USD), 2025-2033
  • Table 3: Global: Gene Expression Analysis Market Forecast: Breakup by Technology (in Million USD), 2025-2033
  • Table 4: Global: Gene Expression Analysis Market Forecast: Breakup by Capacity (in Million USD), 2025-2033
  • Table 5: Global: Gene Expression Analysis Market Forecast: Breakup by End-User (in Million USD), 2025-2033
  • Table 6: Global: Gene Expression Analysis Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 7: Global: Gene Expression Analysis Market: Competitive Structure
  • Table 8: Global: Gene Expression Analysis Market: Key Players
目次
Product Code: SR112025A1832

The global gene expression analysis market size reached USD 5.6 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 11.7 Billion by 2033, exhibiting a growth rate (CAGR) of 8.21% during 2025-2033.

Gene expression analysis (GEA) is the method of extracting data from a gene to investigate the behaviour of biological systems. It involves different processes such as gene transcription, translation, post-translational modification of protein and RNA splicing. The data obtained from this analysis is used for the production of proteins, Ribonucleic Acid (RNA) and various microbiological products. They are further utilized for the development of new drugs and improving the existing diagnostic methods. GEA is now widely considered to be essential in explaining the mechanisms that cause numerous medical ailments, owing to which it finds extensive applications in pharmacogenomics, biomarking, toxicology and diagnostics.

The increasing adoption of targeted molecular therapeutics, along with the growing demand for personalized medicines, is among the key factors driving the growth of the market. GEA has proven to be a powerful tool in molecular biology studies, which are used to understand the functioning of genes, diagnose ailments and facilitate drug development. Furthermore, the growing prevalence of chronic diseases, such as cancer, tuberculosis, and cardiovascular and genetic disorders is providing a significant boost to the market growth. Additionally, the development of personalized medicines to cure these ailments has enabled the modifications of diagnostic and treatment methods according to the individual patient requirement. Moreover, various technological advancements, such as the advent of Next Generation Sequencing (NGS), along with the development of genomic databases, higher success rates of GEA and enhanced focus on research and development (R&D) in gene therapy, are further projected to drive the market growth.

Key Market Segmentation:

Breakup by Products & Services:

  • Consumables
  • Instruments
  • Services

Breakup by Technology:

  • Polymerase Chain Reaction (PCR)
  • Next Generation Sequencing (NGS)
  • DNA Microarray
  • Sanger Sequencing
  • Others

Breakup by Capacity:

  • Low-to Mid-Plex Gene Expression Analysis
  • High-Plex Gene Expression Analysis

Breakup by End-User:

  • Pharmaceutical and Biotech Companies
  • Academic Institutes and Research Centers
  • Others

Breakup by Region:

  • North America
    • United States
    • Canada
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Colombia
    • Chile
    • Peru
    • Others
  • Middle East and Africa
    • Turkey
    • Saudi Arabia
    • Iran
    • United Arab Emirates
    • Others

Competitive Landscape:

The competitive landscape of the industry has also been examined with some of the key players being Agilent Technologies, Inc., BGI Genomics Co., Ltd., Bio-Rad Laboratories, Inc., Eurofins GSC Lux SARL, F. Hoffmann-La Roche Ltd, GE Healthcare, Illumina, Inc., Oxford Gene Technology IP Limited, Pacific Biosciences of California Inc., PerkinElmer Inc., QIAGEN GmbH, Thermo Fisher Scientific Inc. etc.

Key Questions Answered in This Report

  • 1.How big is the global gene expression analysis market?
  • 2.What is the expected growth rate of the global gene expression analysis market during 2025-2033?
  • 3.What are the key factors driving the global gene expression analysis market?
  • 4.What has been the impact of COVID-19 on the global gene expression analysis market?
  • 5.What is the breakup of the global gene expression analysis market based on the product & services?
  • 6.What is the breakup of the global gene expression analysis market based on the technology?
  • 7.What is the breakup of the global gene expression analysis market based on the capacity?
  • 8.What is the breakup of the global gene expression analysis market based on the end-user?
  • 9.What are the key regions in the global gene expression analysis market?
  • 10.Who are the key players/companies in the global gene expression analysis market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Gene Expression Analysis Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact Of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Products & Services

  • 6.1 Consumables
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Instruments
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Services
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Technology

  • 7.1 Polymerase Chain Reaction (PCR)
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Next Generation Sequencing (NGS)
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 DNA Microarray
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Sanger Sequencing
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Others
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast

8 Market Breakup by Capacity

  • 8.1 Low-to Mid-Plex Gene Expression Analysis
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 High-Plex Gene Expression Analysis
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast

9 Market Breakup by End-User

  • 9.1 Pharmaceutical and Biotech Companies
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Academic Institutes and Research Centers
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Others
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Europe
    • 10.2.1 Germany
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 France
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 United Kingdom
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 Italy
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Spain
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Russia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Asia-Pacific
    • 10.3.1 China
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 Japan
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 India
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 South Korea
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Australia
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Indonesia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Argentina
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
    • 10.4.4 Colombia
      • 10.4.4.1 Market Trends
      • 10.4.4.2 Market Forecast
    • 10.4.5 Chile
      • 10.4.5.1 Market Trends
      • 10.4.5.2 Market Forecast
    • 10.4.6 Peru
      • 10.4.6.1 Market Trends
      • 10.4.6.2 Market Forecast
    • 10.4.7 Others
      • 10.4.7.1 Market Trends
      • 10.4.7.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Turkey
      • 10.5.1.1 Market Trends
      • 10.5.1.2 Market Forecast
    • 10.5.2 Saudi Arabia
      • 10.5.2.1 Market Trends
      • 10.5.2.2 Market Forecast
    • 10.5.3 Iran
      • 10.5.3.1 Market Trends
      • 10.5.3.2 Market Forecast
    • 10.5.4 United Arab Emirates
      • 10.5.4.1 Market Trends
      • 10.5.4.2 Market Forecast
    • 10.5.5 Others
      • 10.5.5.1 Market Trends
      • 10.5.5.2 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

  • 12.1 Overview
  • 12.2 Inbound Logistics
  • 12.3 Operations
  • 12.4 Outbound Logistics
  • 12.5 Marketing and Sales
  • 12.6 Service

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Indicators

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Agilent Technologies, Inc.
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
      • 15.3.1.4 SWOT Analysis
    • 15.3.2 BGI Genomics Co., Ltd.
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
    • 15.3.3 Bio-Rad Laboratories, Inc.
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
      • 15.3.3.4 SWOT Analysis
    • 15.3.4 Eurofins GSC Lux SARL
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
    • 15.3.5 F. Hoffmann-La Roche Ltd
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
      • 15.3.5.3 Financials
    • 15.3.6 GE Healthcare
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
    • 15.3.7 Illumina, Inc.
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 Financials
      • 15.3.7.4 SWOT Analysis
    • 15.3.8 Oxford Gene Technology IP Limited
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
    • 15.3.9 Pacific Biosciences of California Inc.
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
    • 15.3.10 PerkinElmer Inc.
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
      • 15.3.10.3 Financials
      • 15.3.10.4 SWOT Analysis
    • 15.3.11 QIAGEN GmbH
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio
      • 15.3.11.3 Financials
    • 15.3.12 Thermo Fisher Scientific Inc.
      • 15.3.12.1 Company Overview
      • 15.3.12.2 Product Portfolio
      • 15.3.12.3 Financials
      • 15.3.12.4 SWOT Analysis